Terumo (OTCMKTS:TRUMY) Hits New 1-Year Low – Time to Sell?

Terumo Corp. (OTCMKTS:TRUMY)’s stock price hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $12.12 and last traded at $12.1267, with a volume of 49556 shares traded. The stock had previously closed at $12.56.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on TRUMY shares. Nomura raised shares of Terumo to a “hold” rating in a research report on Tuesday, February 24th. Zacks Research upgraded shares of Terumo to a “hold” rating in a research report on Thursday, April 9th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat, the stock currently has a consensus rating of “Hold”.

Terumo Price Performance

The company has a current ratio of 1.51, a quick ratio of 0.89 and a debt-to-equity ratio of 0.07. The stock has a 50 day simple moving average of $13.13 and a 200-day simple moving average of $14.10. The firm has a market cap of $17.86 billion, a PE ratio of 20.87 and a beta of 0.62.

Terumo (OTCMKTS:TRUMY) last announced its quarterly earnings data on Friday, February 13th. The company reported $0.14 EPS for the quarter, missing the consensus estimate of $0.15 by ($0.01). Terumo had a net margin of 11.74% and a return on equity of 9.01%. The business had revenue of $1.94 billion during the quarter, compared to analysts’ expectations of $1.82 billion. Equities analysts anticipate that Terumo Corp. will post 0.58 earnings per share for the current fiscal year.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.